Bioeq’s Lucentis Biosimilar Is Given EU Go-Ahead
Launch Dates And Financial Terms Of A Marketing Deal With Teva Remain Under Wraps
• By Rosalind Rei
The Ranivisio ranibizumab biosimilar has been formally approved by the European Commission • Source: Shutterstock 
